CRH Medical Corporation has signed a definitive agreement with Well Health Technologies Corp. (“WELL”), pursuant to which WELL will acquire all of the issued and outstanding shares of CRH for US$4.00 per share, representing an aggregate purchase price of approximately US$292.7 million. The purchase price represents a premium of approximately 83% to the closing price of the Company’s shares on the NYSE American on February 5, 2021 (the last trading day prior to announcement of the transaction).
“This transaction is the logical next step for CRH as WELL adds CRH to its portfolio of healthcare related businesses” commented Tushar Ramani, CEO of the Company. “Since joining the Company, my mandate has been to drive the value of CRH through organic and acquisitive growth, and the results of those efforts are reflected in the premium being paid to shareholders in this transaction.”
Date: Friday, April 16, 2021
Time: 9:00 am PDT
Location: Virtual only https://web.lumiagm.com/281719465
If you are a registered shareholder and want to vote online at our annual meeting:
If you are a guest, you can log into the meeting as set out below. Guests can watch the meeting but are not able to vote.